News & Updates

Chronic catheterization may put individuals at risk of bladder cancer

07 Sep 2021 by

Chronic indwelling or intermittent bladder catheterization contributes to an increased risk of bladder cancer and related mortality, with the highest risk observed among individuals using catheters for almost 3 years as well as those with bladder calculi, as suggested in a recent study.

Chronic catheterization may put individuals at risk of bladder cancer

07 Sep 2021

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

07 Sep 2021 by

An MRI-targeted biopsy* plus a new risk score cuts unnecessary biopsies by half in men with positive MRI results and elevated PSA** levels in the STHLM3-MRI study. This benefit comes without missing clinically significant cancers, experts report at EAU 2021.

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

07 Sep 2021

Incident diabetes after hormone therapy ups risk of progression to CRPC

06 Sep 2021

In prostate cancer (PC) patients undergoing hormone therapy, the development of lifestyle-related disorders, particularly diabetes mellitus (DM), predicts an earlier progression to castration-resistant PC (CRPC) and poor prognosis, a recent study has found.

Incident diabetes after hormone therapy ups risk of progression to CRPC

06 Sep 2021

Mirabegron effective for paediatric NDO patients

06 Sep 2021 by

The β3-adrenoreceptor agonist mirabegron – a proven effective treatment for overactive bladder and neurogenic detrusor overactivity (NDO) in adults – was equally as effective in children and adolescents with NDO, a phase III study suggests.

Mirabegron effective for paediatric NDO patients

06 Sep 2021

Robot-assisted radical prostatectomy improves symptoms in moderate, severe LUTS

28 Aug 2021

Robot-assisted radical prostatectomy (RARP) helps improve symptoms and quality of life (QoL) in patients with moderate or severe lower urinary tract symptoms (LUTS), a recent study has found.

Robot-assisted radical prostatectomy improves symptoms in moderate, severe LUTS

28 Aug 2021

High urine cotinine levels may signal bladder cancer recurrence

26 Aug 2021 by

High levels of cotinine in the urine of smokers who have undergone resection for non-muscle invasive bladder cancer (NMIBC) could be a sign of cancer recurrence, according to a study from Lebanon presented at EAU21.

High urine cotinine levels may signal bladder cancer recurrence

26 Aug 2021

Daily mouthwash use does not prevent oropharyngeal gonorrhoea

25 Aug 2021 by

Daily use of a mouthwash which has demonstrated inhibition of Neisseria gonorrhoeae (N. gonorrhoeae) growth in vitro did not reduce the risk of oropharyngeal gonorrhoea in men who have sex with men (MSM), according to results of the OMEGA* study from Australia.

Daily mouthwash use does not prevent oropharyngeal gonorrhoea

25 Aug 2021

Adjuvant nivolumab confers survival benefit for bladder cancer

25 Aug 2021 by

In patients with high-risk muscle-invasive urothelial carcinoma (miUC) who had undergone radical surgery, disease-free survival (DFS) was longer among those who received adjuvant nivolumab vs those on placebo, according to interim findings from the phase III CheckMate 274 trial.

Adjuvant nivolumab confers survival benefit for bladder cancer

25 Aug 2021

Thulium trumps holmium laser enucleation for benign prostate hyperplasia

20 Aug 2021

Thulium (ThuLEP) compared with holmium (HoLEP) laser enucleation of prostate yields faster symptom improvement and better safety outcomes in patients with benign prostatic hyperplasia (BPH), a recent meta-analysis has found.

Thulium trumps holmium laser enucleation for benign prostate hyperplasia

20 Aug 2021

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021 by

In individuals with neurogenic detrusor overactivity incontinence (NDOI) who were regularly undergoing clean intermittent catheterization, significant reductions of urinary incontinence episodes were seen following treatment with abobotulinumtoxinA (aboBoNT-A), according to a pooled analysis of two CONTENT studies presented at EAU 2021.

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Chronic catheterization may put individuals at risk of bladder cancer

Chronic catheterization may put individuals at risk of bladder cancer

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

Incident diabetes after hormone therapy ups risk of progression to CRPC

Incident diabetes after hormone therapy ups risk of progression to CRPC

Mirabegron effective for paediatric NDO patients

Mirabegron effective for paediatric NDO patients

Robot-assisted radical prostatectomy improves symptoms in moderate, severe LUTS

Robot-assisted radical prostatectomy improves symptoms in moderate, severe LUTS

High urine cotinine levels may signal bladder cancer recurrence

High urine cotinine levels may signal bladder cancer recurrence

Daily mouthwash use does not prevent oropharyngeal gonorrhoea

Daily mouthwash use does not prevent oropharyngeal gonorrhoea

Adjuvant nivolumab confers survival benefit for bladder cancer

Adjuvant nivolumab confers survival benefit for bladder cancer

Thulium trumps holmium laser enucleation for benign prostate hyperplasia

Thulium trumps holmium laser enucleation for benign prostate hyperplasia

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI